SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism

Frieman, Matthew B., Chen, Jun, Morrison, Thomas E., Whitmore, Alan, Funkhouser, William, Ward, Jerrold M., Lamirande, Elaine W., Roberts, Anjeanette, Heise, Mark, Subbarao, Kanta, Baric, Ralph S.·2010·PLoS Pathogens
DOI 10.1371/journal.ppat.1000849

Cited by (162)

Items 101–162 of 162

  1. Porcine Epidemic Diarrhea Virus Antagonizes Host IFN-λ-Mediated Responses by Tilting Transcription Factor STAT1 toward Acetylation over Phosphorylation To Block Its Activation
    Jidong Xu, Qin Feng Gao, Weiwu Zhang, Jingyou Zheng, Rong Chen, Xiao Ming Han, Junyong Mao, Ying Shan, Fushan Shi, Fang He et al. · 2023 · mBio
  2. Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses
    Adam S. Cockrell, Anne E. Beall, Boyd L. Yount, Ralph Steven Baric · 2017 · Methods in molecular biology
  3. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
    Vijay Kumar · 2020 · International Reviews of Immunology
  4. Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
    John Ross Teijaro · 2016 · Advances in immunology
  5. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
    Shukur Wasman Smail, Muhammad Saeed, Twana Alkasalias, Zhikal Omar Khudhur, Delan Ameen Younus, Mustafa Fahmi Rajab, Wayel Habib Abdulahad, Hafiz Iftikhar Hussain, Kamal Niaz, Muhammad Safdar · 2021 · Food and Chemical Toxicology
  6. Chemokine Regulation During Epidemic Coronavirus Infection
    Shamik Majumdar, Philip M. Murphy · 2021 · Frontiers in Pharmacology
  7. Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
    Adam S. Cockrell, Sarah R. Leist, Madeline G. Douglas, Ralph Steven Baric · 2018 · Mammalian Genome
  8. Coronaviruses Associated with the Superfamily Musteloidea
    Alison E. Stout, Qinghua Guo, Jean K. Millet, Ricardo de Matos, Gary R. Whittaker · 2021 · mBio
  9. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN- γ as a Novel Antiviral Approach Against COVID-19
    Faisal Rasheed Anjum, Sidra Anam, Ghazanfar Abbas, Muhammad Shahid Mahmood, Sajjad Ur Rahman, Mohsan Ullah Goraya, Rana Muhammad Abdullah, Muhammad Luqman, Ashiq Ali, Muhammad Kamran et al. · 2020 · Viral Immunology
  10. Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae
    Miha Tome, Jure Zupan, Zorica Tomičić, Tadeja Matos, Peter Raspor · 2018 · PeerJ
  11. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers
    Aarón Vázquez-Jiménez, Ugo Avila-Ponce de León, Meztli L. Matadamas-Guzman, Erick Andrés Muciño-Olmos, Yoscelina Estrella Martínez-López, Thelma Escobedo-Tapia, Osbaldo Reséndis-Antonio · 2021 · Frontiers in Immunology
  12. Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
    Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Rajesh Jeewon, Jian‐Dong Huang, Siva Sundara Kumar Durairajan · 2022 · World Journal of Virology
  13. SARS-CoV nucleocapsid protein interacts with cellular pyruvate kinase protein and inhibits its activity
    Wei‐Yen Wei, Hui-Chun Li, Chiung Yao Chen, Chee-Hing Yang, Shen-Kao Lee, Chia‐Wen Wang, Hsin-Chieh Ma, Yue‐Li Juang, Shih‐Yen Lo · 2012 · Archives of Virology
  14. Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection
    Ashleigh Nichole Riegler, Paul V. Benson, Kenneth D. Long, Sixto Manuel Leal · 2023 · Cell Death Discovery
  15. Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19
    Fabrizio Galimberti, Jeffrey McBride, Megan M. Cronin, Yumeng Li, JOSHUA L. FOX, Michael E. Abrouk, Alexander T. Herbst, Robert Scott Kirsner · 2020 · Clinics in Dermatology
  16. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
    Joseph K. Sampson Duncan, Danyang Xu, María Licursi, Michael Joyce, Holly A. Saffran, Kaiwen Liu, Jin Gohda, D. Lorne Tyrrell, Yasushi Kawaguchi, Kensuke Hirasawa · 2023 · Frontiers in Immunology
  17. Methicillin resistant Staphylococcus aureus adhesion to human umbilical vein endothelial cells demonstrates wall shear stress dependent behaviour
    Kayla D. Viegas, Sharul Sham Dol, Mohammad Mehdi Salek, Robert D. Shepherd, Robert John Martinuzzi, Kristina D. Rinker · 2011 · BioMedical Engineering OnLine
  18. Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad
    Manuela Piazzi, Alberto Bavelloni, Irene Faenza, William L. Blalock · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  19. Human coronaviruses: activation and antagonism of innate immune responses
    Nikhila S. Tanneti, Helen A. Stillwell, Susan Reich Weiss · 2024 · Microbiology and Molecular Biology Reviews
  20. An Integrative Analysis Identifying Transcriptional Features and key Genes Involved in COVID-19
    Guoping Li, Junyi Wang, Xiang He, Lei Zhang, Ran Qin, Anying Xiong, Dehong Wu, Lingjuan Hu, Qi Song, Dong Mei Zhu · 2020 · Epigenomics
  21. Molecular determinants of cross-species transmission in emerging viral infections
    Arthur Wickenhagen, Sarah van Tol, Vincent Jacobus Munster · 2024 · Microbiology and Molecular Biology Reviews
  22. Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists?
    Jayakanthan Kabeerdoss, Debashish Danda · 2020 · International Journal of Rheumatic Diseases
  23. Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
    Pureum Lee, Doo-Jin Kim · 2020 · Immune Network
  24. Interferons in coronavirus pathogenesis: The good, the bad, and the ugly
    Rudragouda Channappanavar · 2022 · Cell Host & Microbe
  25. Deciphering molecular mechanisms of SARS-CoV-2 pathogenesis and drug repurposing through GRN motifs: a comprehensive systems biology study
    Marzieh Sameni, Seyed Amir Mirmotalebisohi, Zeinab Dehghan, Raziyeh Abooshahab, Yalda Khazaei‐Poul, Maryam Mozafar, Hakimeh Zali · 2023 · 3 Biotech
  26. Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing
    Ahsan Anjoom Sunil, Tom Skaria · 2022 · Expert Opinion on Therapeutic Targets
  27. Murine norovirus inhibits B cell development in the bone marrow of STAT1-deficient mice
    Charlie C. Hsu, Stacey M. Meeker, Sydney M. Escobar, Thea Brabb, Jisun Paik, Heon Park, Brian M. Iritani, Lillian Maggio‐Price · 2017 · Virology
  28. Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19
    Enrique J. deAndrés‐Galiana, Juan Luis Fernández‐Martínez, Óscar Álvarez-Machancoses, Guillermina Bea, Carlos María Galmarini, Andrzej Kloczkowski · 2022 · Computers in Biology and Medicine
  29. Severe acute respiratory syndrome (SARS)
    Lisa A. Beltz · 2022 · Elsevier eBooks
  30. Immune responses to human respiratory coronaviruses infection in mouse models
    Zhen Zhuang, Donglan Liu, Jing Sun, Fang Li, Jincun Zhao · 2021 · Current Opinion in Virology
  31. Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2
    Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, Paul J. Baker, Samuel I. Old, Victoria Peluf, Eduardo P. Amaral, Sandra D. Oland, Danielle O’Mard, Julie Laux et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  32. COVID-19 as a Potential Target for Cryobiology and Cryomedicine
    Аnatoliy Goltsev, Barry J. Fuller, Mykola O. Bondarovych, Natalya Babenko, Yuliya Gaevska, Iryna A. Buriak, Т. Г. Дубрава, Kateryna Yampolska, Olena D. Lutsenko, Maksim V. Ostankov · 2020 · Problems of Cryobiology and Cryomedicine
  33. The Pandemic of Coronavirus Disease 2019 (COVID-19)
    Nurshamimi Nor Rashid · 2021 · Current Molecular Medicine
  34. LINC01002 functions as a ceRNA to regulate FRMD8 by sponging miR-4324 for the development of COVID-19
    Xinyi Kong, Qinjin Wang, Xumeng Wang, Kaming Yang, Shuping Nie, Yuetong Li, Wanwen Lao, Xin Yu, Yanping Zhang, Zhenlin Li et al. · 2024 · Virology Journal
  35. Computational Design of Membrane Curvature-Sensing Peptides
    Armando Jerome de Jesus, Hang Hubert Yin · 2016 · Methods in molecular biology
  36. In-vitro and In-vivo Experimental Models for MERS-CoV, SARSCoV, and SARS-CoV-2 Viral Infection: A Compendious Review
    Sonia Kaur Singh, Aman Kumar, Himanshu Sharma · 2022 · Recent Patents on Biotechnology
  37. Review of immune responses correlated with COVID-19 outcomes: the fight, debacle and aftermath in the Indonesian context
    Dian Eurike Septyaningtrias, Jajah Fachiroh, Dewi Kartikawati Paramita, Dewajani Purnomosari, Rina Susilowati · 2020 · Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
  38. Caring for patients with rare diseases during the COVID-19 pandemic
    Mohamed Boudjelal, Nimer Mehyar, Bandar Alghanem, Faisal Almajed, Majid Alfadhel · 2021 · The Journal of Infection in Developing Countries
  39. Diffuse Alveolar Damage in a Young Cat
    Ryosuke Kobayashi, Shigeki Yamano, Katsuyuki Tanaka, Junichi Kamiie, Kinji Shirota · 2011 · Journal of Veterinary Medical Science
  40. Severe Acute Respiratory Syndrome
    Frederick J. Cassels · 2012
  41. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach
    Zeinab Dehghan, Seyed Amir Mirmotalebisohi, Maryam Mozafar, Marzieh Sameni, Fatemeh Saberi, Amin Derakhshanfar, Javad Moaedi, Hassan Zohrevand, Hakimeh Zali · 2024 · DARU Journal of Pharmaceutical Sciences
  42. An insight into the use of transgenic animal models for conducting research on coronavirus
    Akila Prashant, Supriya Bevinakoppamath, Shobha Chikkavaddaragudi Ramachandra · 2020 · International Journal of Health & Allied Sciences
  43. Interstitial lung diseases and COVID-19
    Funda Çoşkun, Pınar Yıldız Gülhan, Nilgün Yılmaz Demirci, Fulsen Bozkuş, Onur Yazıcı · 2020 · Eurasian Journal of Pulmonology
  44. Type I IFN promotes pathogenic inflammatory monocyte maturation during H5N1 infection
    Slim Fourati, David Jimenez‐Morales, Judd F. Hultquist, Max W. Chang, Christopher W. Benner, Nevan J. Krogan, Lars Pache, Sumit K. Chanda, Rafick‐Pierre Sékaly, Adolfo García‐Sastre et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  45. COVID-19: a review from origin to immune responses
    Arefe Vafaeinezhad, Mohammad Reza Atashzar, Rasoul Baharlou · 2022
  46. InfectionsMice from Lethal Respiratory Virus Intranasal Treatment with Poly(I·C) Protects
    Stanley M. Perlman, Erica Fleming, Thomas E. Lane, Paul B. McCray, Jincun Zhao, Christine Wohlford-Lenane, Jingxian Zhao · 2012
  47. SARS CORONAVIRUS ANTAGONIZES INNATE IMMUNE SIGNALING INITIATED BY RIG-I BUT IS RECOGNIZED BY TLR SIGNALING VIA THE ADAPTOR MOLECULE TRIF
    Allison L. Totura · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  48. Liberty and Pandemics: A Libertarian Approach to the Global COVID-19 Situation
    Habeeb Asudemade · 2020 · SSRN Electronic Journal
  49. The Respiratory Tract
    Jerrold Michael Ward, John P. Sundberg · 2021 · Wiley eBooks
  50. Animal Models for SARS-CoV-2 research: Systematic Review of Literature and Future Directions
    Kabita Pandey, Arpan Acharya, Mahesh Mohan, Caroline Ng, Patrick Reid, Siddappa N. Byrareddy · 2020
  51. Antiviral roles of interferon regulatory factor (IRF)-1, 3 and 7 against human coronavirus infection
    Danyang Xu, Joseph K. Sampson Duncan, María Licursi, Jin Gohda, Yasushi Kawaguchi, Kensuke Hirasawa · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights
    James F. Flynn, Mehdi M. Ahmadi, Chase T. McFarland, Michael Kubal, Mark A. Taylor, Cheng Zhang, Enrique C. Torchia, Michael G. Edwards · 2023 · Biology Methods and Protocols
  53. UNVEILING THE PATHOPHYSIOLOGICAL LANDSCAPE OF COVID-19: INSIGHTS FOR NOVEL THERAPEUTIC STRATEGIES
    Laiba Iqbal, Naila Iqbal, Maaz Khan · 2024 · Pakistan Journal of Scientific Research
  54. Genetic Architecture of Host Proteins Involved in SARS-CoV
    Hayat Khan, Firasat Hussain, Muhammad Adnan, Muhammad Naveed Nawaz, Inam Ullah Khan, Umair Younas, Muhammad Farrukh Nisar, Imtiaz Ali Khan, Muhammad Kalim, Chen Shanyuan et al. · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  55. Additional file 2 of LINC01002 functions as a ceRNA to regulate FRMD8 by sponging miR-4324 for the development of COVID-19
    Kong, Xinyi, Qinjin Wang, Wang, Xumeng, Kaming Yang, Nie, Shuping, Li, Yuetong, Wanwen Lao, Xin Yu, Zhang, Yanping, Li, Zhenlin et al. · 2024 · Figshare
  56. Additional file 1 of LINC01002 functions as a ceRNA to regulate FRMD8 by sponging miR-4324 for the development of COVID-19
    Kong, Xinyi, Qinjin Wang, Wang, Xumeng, Kaming Yang, Nie, Shuping, Li, Yuetong, Wanwen Lao, Xin Yu, Zhang, Yanping, Li, Zhenlin et al. · 2024 · Figshare
  57. Minor differences in the untranslated regions of measles vector additional transcription units are reflected by differential immunogenicity of encoded MERS-CoV Spike antigen
    Vishaka Tiwarekar, Aileen Ebenig, Yvonne Predota, Sabrina Schrauf, Cindy Hörner, Mona V. Lange, Mohamed Rasheed Gadalla, Arne Auste, Csaba Miskey, Samada Muraleedharan et al. · 2026 · Journal of Virology
  58. Host Factor Experiment (EjuanesL_AUM_02_Mouse_Lung_Expression)
    J. Craig Venter Institute, University of Chicago · 2014 · Virus Pathogen Resource
  59. Host Factor Experiment (SCL005-R)
    J. Craig Venter Institute, University of Chicago · 2011 · Virus Pathogen Resource
  60. Host Factor Experiment (SCL005-P)
    J. Craig Venter Institute, University of Chicago · 2014 · Virus Pathogen Resource
  61. Host Factor Experiment (SM001-R)
    J. Craig Venter Institute, University of Chicago · 2011 · Virus Pathogen Resource
  62. Host Factor Experiment (EjuanesL_AUM_01_VE6_MA104_Expression)
    J. Craig Venter Institute, University of Chicago · 2012 · Virus Pathogen Resource